Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New PEG3350 Formulation in Constipated Children
NCT00583609Phase 4Completed
- Sponsor
- Braintree Laboratories
- Start
- Sep 2007
- Primary completion
- Jul 2008
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polyethylene glycol 3350 in constipation, sponsored by Braintree Laboratories. Primary endpoint: Patient self reported bowel movement (BM) data at 2 weeks. Started Sep 2007; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
constipation
Beyond the preview
Go deeper on NCT00583609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583609.